Welcome to our dedicated page for ENVXW SEC filings (Ticker: ENVXW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The ENVXW SEC filings page focuses on regulatory documents related to the Enovix Corporation warrants that traded under the ENVXW symbol. These filings help explain how the warrant program was structured, how it evolved over time, and how the ENVXW class was ultimately removed from listing on the Nasdaq Stock Market.
Key filings include multiple Form 8-K reports in which Enovix describes material events affecting the warrants. These 8-Ks summarize press releases announcing the distribution of the warrants as a dividend, the satisfaction of early expiration price conditions tied to the volume-weighted average price of Enovix common stock, the election of an alternate expiration date, and the mechanics by which warrants had to be exercised before they became void. The filings also reference a Notice of Guaranteed Delivery that outlined procedures for warrant holders whose financial institutions could not complete exercises before the deadline.
A central document for ENVXW is the Form 25 filed with the SEC, in which Nasdaq notified the Commission of the removal of the Enovix warrant class from listing and registration under Section 12(b) of the Exchange Act. This filing confirms that the ENVXW warrants, described simply as “Warrant” in the form, were struck from the exchange following the conclusion of the program.
Through Stock Titan, users can access these filings as they appear on EDGAR, while AI-powered tools can assist in interpreting the implications. For ENVXW, that means quickly understanding the timeline from warrant issuance to expiration, the conditions that triggered early expiration, and the formal delisting process. Users interested in Enovix more broadly can also look to related filings under ENVX for annual reports on Form 10-K, quarterly reports on Form 10-Q, and additional 8-Ks that discuss financial results, capital markets transactions and governance changes.
In addition, investors researching historical capital structure or derivative securities can use the ENVXW filings to see how the warrant terms were documented in the warrant agreement, how the company communicated with holders, and how proceeds from exercises were reported in subsequent disclosures. AI summaries can highlight the sections that address warrant exercise prices, expiration conditions, and the impact on Enovix’s equity.
Enovix Corp President and CEO Rajendra K. Talluri had 4,301 shares of common stock withheld on June 8, 2026 to cover tax obligations tied to vesting restricted stock units (RSUs). The shares were valued at $7.32 each for the withholding calculation.
After this tax-withholding disposition, Talluri holds 3,062,266 shares directly, a figure that includes 1,989,823 shares issuable upon vesting and settlement of RSUs. His position also reflects 47,775 vested performance RSUs scheduled for release in March 2027 and 259,611 additional performance RSUs, half to be released in April 2027 and the rest in April 2028.
Enovix Corp reported that Chief Legal Officer Arthi Chakravarthy had 936 shares of common stock withheld at $7.32 per share to cover tax obligations tied to vesting restricted stock units. After this tax-withholding disposition, she holds 603,576 common shares, including 389,432 shares issuable from RSUs and additional performance RSUs scheduled for release between March 2027 and April 2028.
Enovix Corp Chief Accounting Officer Kristina Truong reported routine equity compensation activity involving restricted stock units. On May 29, 2026 she received 5,718 shares of common stock from a fully vested RSU award, with 3,028 shares withheld at $7.98 per share to cover tax obligations. After these transactions, she directly held 315,622 shares of Enovix common stock, including shares underlying previously granted RSUs and performance RSUs that will be settled in 2027 and 2028.
Enovix Corp Chief Legal Officer Arthi Chakravarthy reported routine equity compensation activity. On May 29, 2026, she received 6,756 shares of common stock at no cost as a fully vested RSU bonus for the quarter ended April 5, 2026, and 3,578 shares were withheld to cover tax obligations. Following these transactions, she directly holds 604,512 common shares, in addition to a substantial mix of unvested RSUs and earned performance RSUs scheduled to settle between 2027 and 2028.
Enovix Corp Chief Financial Officer Ryan A. Benton reported routine equity compensation activity involving restricted stock units (RSUs). On May 29, 2026, he received 5,103 shares of common stock as a fully vested RSU award bonus for the quarter ended April 5, 2026, and 2,703 shares were withheld to cover related tax obligations. Following these transactions, he directly owned 925,368 shares of Enovix common stock, including 848,005 shares issuable upon future vesting and settlement of RSUs. These events reflect compensation and tax withholding mechanics, not open-market stock purchases or sales.
Enovix Corp President and CEO Rajendra K. Talluri reported routine equity compensation and related tax withholding in company stock. He received 17,794 shares of common stock at no cost on May 29, 2026 from a fully vested restricted stock unit (RSU) bonus for the quarter ended April 5, 2026.
To cover tax obligations on this award, 9,422 shares were withheld at $7.98 per share, a non-market disposition. After these transactions, he is reported as beneficially owning 3,066,567 shares, including 1,997,944 shares issuable upon RSU vesting and additional performance RSUs scheduled to settle in 2027 and 2028.
Enovix Corp Chief Legal Officer Arthi Chakravarthy reported a routine tax-related share disposition. On the reported date, 2,221 shares of Enovix common stock were withheld at $6.68 per share to cover tax obligations tied to vesting restricted stock units. After this withholding, Chakravarthy directly held 601,334 shares. The position includes 391,199 shares issuable from unvested RSUs and performance-based awards scheduled to settle between March 2027 and April 2028, indicating a substantial remaining equity stake.
Enovix Corp President and CEO Rajendra K. Talluri reported a tax-related share disposition tied to equity compensation. On the vesting of restricted stock units, 17,650 shares of common stock were withheld at $5.93 per share to satisfy tax withholding obligations, rather than sold on the open market.
After this withholding, Talluri directly holds 3,058,195 shares of Enovix common stock. This includes 1,997,944 shares issuable upon vesting and settlement of RSUs, plus 47,775 vested PRSUs scheduled for release in March 2027 and 259,611 additional PRSUs to be released in April 2027 and April 2028.
Enovix Corp Chief Accounting Officer Kristina Truong reported a routine tax-related share disposition. On the RSU vesting date, 1,014 shares of common stock were withheld at $7.29 per share to cover tax obligations, rather than sold in the open market.
After this withholding, she directly holds 312,932 shares, which include 221,086 shares tied to unvested RSUs and vested performance RSUs totaling 2,489 shares scheduled for release in March 2027 and 35,278 shares scheduled for release in April 2027 and April 2028.
Enovix Corporation reported first quarter 2026 revenue of $7.6 million, up 49% year-over-year and above the high end of its guidance. Growth was driven mainly by defense and industrial shipments from its South Korea operations. GAAP gross margin improved to 20.4%, while non-GAAP gross margin reached 26.3%, marking a sixth consecutive quarter of positive gross profit.
The company posted a GAAP net loss of $38.3 million, or $0.18 per share, and a non-GAAP net loss of $29.5 million, or $0.14 per share. Net cash used in operating activities was $33.1 million, and free cash flow was an outflow of $36.3 million. Enovix ended the quarter with $582.7 million in cash, cash equivalents and marketable securities.
Operationally, Enovix advanced smartphone battery qualification, began initial smart eyewear battery shipments, and launched its MX-1 drone battery platform. For the second quarter of 2026, it guided revenue to $8.0–$9.0 million, non-GAAP loss from operations to $29.0–$32.0 million, and capital expenditures to $9.0–$13.0 million.